EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis

Sylvain Metral, Sandrine Genetet, Benoît Gamain, Isabelle Mouro-Chanteloup

Scientific Reports · 2024

DOI: 10.1038/s41598-024-76897-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Sylvain Metral und 3 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité and Université des Antilles, Inserm U1134, BIGR, Paris, France. Hauptthemen laut MEDLINE: Erythropoiesis, Cell Differentiation. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Labex.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New hematopoietic cell models have recently emerged through immortalization of CD34 cells to study and understand various molecular mechanisms of erythropoiesis. Here, we characterize the JK-1 CML-derived cell line, previously shown to spontaneously differentiate without cytokines. Using an epigenetic differentiation inhibitor that keeps JK-1 in an early differentiation phase, we characterized 2 progenitor stages: BFU-E JK-1 and CFU-E JK-1 with CD34+/CD36- and CD34-/CD36 + phenotypes respectively. Then, using the PFI-1 inducer known to synchronously control the terminal differentiation of JK-1 cells, 5 precursor stages were obtained (ProE, Baso1-2, PolyC, OrthoC) and characterized via cell morphology, CD49a and Band3 markers. Enlarged phenotyping was carried out for the earlier phase, and expression kinetics of membrane proteins such as RhAG, RhD/CE, CD47, DARC and CD44 were performed on each stage of the terminal phase. Furthermore, since JK-1 offers the unique property of covering a broad spectrum of differentiation stages, we explored deeper the GATA2/GATA1 and the non-erythroid/erythroid spectrin 'switching'. The possibility of obtaining large quantities of JK-1 cells at each stage of differentiation, as shown in this study, as well as the potential to genetically modify these cells, via CrisprCas9, makes their use of considerable interest for studying pathologies occurring during erythropoiesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythropoiesisCell DifferentiationHumansCell Line, TumorLeukemia, Erythroblastic, AcuteErythroid Precursor CellsAntigens, CD34

Stichwörter der Autor:innen

ErythropoiesisExpression switchingJK-1 cellsPrecursorProgenitor

Substanzen

Antigens, CD34

Autor:innen und Institutionen

  • Université Paris Cité and Université des Antilles, Inserm U1134, BIGR, Paris, France.
  • Sorbonne Université, Inserm U1135, CNRS ERL 8255, Paris, France.
  • Centre d'Immunologie et des Maladies Infectieuses, Faculté de médecine Sorbonne Université, 5e étage - Bureau 506 91 boulevard de l'Hôpital, 75013, Paris, France.
  • Sorbonne Université, Inserm U1135, CNRS ERL 8255, Paris, France. isabelle.mouro-chanteloup@inserm.fr.
  • Centre d'Immunologie et des Maladies Infectieuses, Faculté de médecine Sorbonne Université, 5e étage - Bureau 506 91 boulevard de l'Hôpital, 75013, Paris, France. isabelle.mouro-chanteloup@inserm.fr.

Förderung

  • Labex

Zitieren

APA

Metral, S., Genetet, S., Gamain, B., & Mouro-Chanteloup, I. (2024). JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis. Scientific Reports. https://doi.org/10.1038/s41598-024-76897-7

Vancouver

Metral S, Genetet S, Gamain B, Mouro-Chanteloup I. JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis. Scientific Reports. 2024. doi:10.1038/s41598-024-76897-7

BibTeX
@article{Metral2024,
  author = {Metral, Sylvain and Genetet, Sandrine and Gamain, Benoît and Mouro-Chanteloup, Isabelle},
  title = {JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis},
  journal = {Scientific Reports},
  year = {2024},
  doi = {10.1038/s41598-024-76897-7}
}
Kostenlos starten →